Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

GGuardant Health, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
G

Guardant Health, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • History
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $334.98M. Net result −$120.14M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $334.98M. Running result $334.98M. Oncology: $219.11M. Licensing Other: $2.06M. Screening: $52.87M. Biopharma Data: $60.95M.
  • Cost of revenue: −$115.95M. Running result $219.03M.
  • Gross profit: $219.03M. Running result $219.03M.
  • Research and development expense: −$96.53M. Running result $122.5M.
  • Sales and marketing expense: −$189.95M. Running result −$67.46M.
  • General and administrative expense: −$61.66M. Running result −$129.12M.
  • Operating income: −$129.12M. Running result −$129.12M.
  • Other income: $9.16M. Running result −$119.96M.
  • Pre-tax loss: −$119.96M. Running result −$119.96M.
  • Income tax expense: −$185K. Running result −$120.14M.
  • Net loss: −$120.14M. Running result −$120.14M.